Ovulatory Disorders Indian Medical PG Practice Questions and MCQs
Practice Indian Medical PG questions for Ovulatory Disorders. These multiple choice questions (MCQs) cover important concepts and help you prepare for your exams.
Ovulatory Disorders Indian Medical PG Question 1: Which of the following is the most reliable test for ovulation?
- A. Basal body temperature
- B. Vaginal cytology
- C. Serum Progesterone level (Correct Answer)
- D. Endometrial biopsy
Ovulatory Disorders Explanation: ***Serum Progesterone level***
- A **serum progesterone level** measured approximately 7 days after the presumed ovulation (mid-luteal phase) is the most reliable biochemical indicator of ovulation. A level of **≥3 ng/mL** confirms ovulation.
- The rise in progesterone is due to its production by the **corpus luteum** formed after the rupture of the mature follicle during ovulation.
*Basal body temperature*
- **Basal body temperature (BBT)** charting shows a slight increase (0.5-1.0°C) after ovulation due to the thermogenic effect of progesterone. However, this rise is **retrospective** and only indicates that ovulation has already occurred.
- BBT can be influenced by various factors, such as illness, stress, and sleep patterns, making it **less precise** than direct hormonal measurement.
*Vaginal cytology*
- **Vaginal cytology** can show changes in epithelial cell morphology (e.g., increased cornified cells) during the periovulatory period due to estrogen influence.
- These changes are **indicative of estrogen activity** and cervical mucus quality, but they do not directly confirm the rupture of the follicle or the release of an egg.
*Endometrial biopsy*
- An **endometrial biopsy** can reveal secretory changes in the endometrium characteristic of the luteal phase, which are a result of progesterone production after ovulation.
- However, this is an **invasive procedure** and not a practical or primary test used solely for confirming ovulation.
Ovulatory Disorders Indian Medical PG Question 2: Which serum level is increased in premature ovarian failure?
- A. Serum Inhibin
- B. Serum FSH (Correct Answer)
- C. Serum Estradiol
- D. Serum Progesterone
Ovulatory Disorders Explanation: ***Serum FSH***
- In **premature ovarian failure**, the ovaries fail to produce sufficient estrogen and inhibin, leading to a loss of negative feedback on the pituitary gland.
- This lack of negative feedback results in continuously **elevated levels of FSH** as the pituitary tries to stimulate the non-responsive ovaries.
*Serum Inhibin*
- **Inhibin** is a hormone produced by ovarian granulosa cells, which normally inhibits FSH secretion.
- In premature ovarian failure, due to ovarian dysfunction, **inhibin levels are typically decreased**, not increased.
*Serum Estradiol*
- **Estradiol** is the primary estrogen produced by the ovaries.
- In premature ovarian failure, the ovaries are failing, resulting in **decreased production of estrogen/estradiol**.
*Serum Progesterone*
- **Progesterone** is primarily produced after ovulation by the corpus luteum.
- In premature ovarian failure, ovulation is impaired or absent, leading to **low or undetectable progesterone levels**.
Ovulatory Disorders Indian Medical PG Question 3: A female patient presents with hirsutism, amenorrhea, and obesity. What is the most likely diagnosis?
- A. Androgen-secreting ovarian tumor
- B. Congenital adrenal hyperplasia
- C. Cushing's syndrome
- D. Polycystic Ovary Syndrome (PCOS) (Correct Answer)
Ovulatory Disorders Explanation: ***Polycystic Ovary Syndrome (PCOS)***
- **Hirsutism**, **amenorrhea** (or oligomenorrhea), and **obesity** are classic clinical features of PCOS, reflecting hyperandrogenism and insulin resistance [2].
- PCOS is a diagnosis of exclusion and involves chronic anovulation and polycystic ovaries on ultrasound [3], though these are not explicitly mentioned, the constellation of symptoms strongly points to it.
*Androgen-secreting ovarian tumor*
- While it can cause **hirsutism** and **amenorrhea**, the onset is typically **rapid** and severe, with very high androgen levels, and obesity is not a primary feature.
- Ovarian tumors are generally less common than PCOS and may present with a palpable mass or specific imaging findings.
*Congenital adrenal hyperplasia*
- This genetic condition often presents in childhood or adolescence with varying degrees of **virilization** and menstrual irregularities due to enzyme deficiencies in cortisol synthesis [1].
- While it causes **hirsutism** and potentially **amenorrhea**, obesity is not a direct consequence, and the patient's age of presentation and specific symptom pattern are less typical for adult-onset CAH in this context.
*Cushing's syndrome*
- Characterized by **central obesity**, **moon facies**, **buffalo hump**, **striae**, and proximal muscle weakness due to chronic glucocorticoid excess.
- Although it can cause **menstrual irregularities** and mild **hirsutism** [2], the overall clinical picture including the absence of other specific Cushingoid features makes it less likely than PCOS.
Ovulatory Disorders Indian Medical PG Question 4: A lady presents with amenorrhea and galactorrhea. What is the most likely cause?
- A. None of the options
- B. Pituitary adenoma (Correct Answer)
- C. Adrenal hyperplasia
- D. 7α-hydroxylase deficiency
Ovulatory Disorders Explanation: ### Pituitary adenoma
- A **prolactin-secreting pituitary adenoma** (prolactinoma) is the most common cause of sustained **hyperprolactinemia**, leading to both **amenorrhea** and **galactorrhea** [1].
- **Elevated prolactin levels** inhibit gonadotropin-releasing hormone (GnRH) pulsatility, leading to reduced LH and FSH, causing anovulation and amenorrhea, alongside direct stimulation of breast tissue for galactorrhea [1], [2].
### *None of the options*
- This option is incorrect as **pituitary adenoma** is a highly plausible cause for the presented symptoms.
- The combination of **amenorrhea** and **galactorrhea** is a classic presentation of hyperprolactinemia, often due to a pituitary adenoma [1].
### *Adrenal hyperplasia*
- **Adrenal hyperplasia** typically involves overproduction of androgens or cortisol, leading to symptoms like **hirsutism**, **virilization**, or **Cushing's syndrome**, rather than galactorrhea [3].
- While it can cause menstrual irregularities, it does not directly cause **galactorrhea**, which is primarily linked to prolactin excess [1], [3].
### *7α-hydroxylase deficiency*
- **7α-hydroxylase deficiency** is a rare genetic disorder affecting **bile acid synthesis**, not directly related to reproductive hormones or prolactin regulation.
- Its clinical manifestations are primarily related to **liver disease** due to abnormal bile acid metabolism and would not present with amenorrhea and galactorrhea.
Ovulatory Disorders Indian Medical PG Question 5: During the evaluation of secondary amenorrhea in a 24-year-old woman, hyperprolactinemia is diagnosed. Which of the following conditions could cause increased circulating prolactin concentrations and amenorrhea in this patient?
- A. Stress
- B. Hypothyroidism (Correct Answer)
- C. Eating disorders
- D. Adrenal disorders
Ovulatory Disorders Explanation: ***Hypothyroidism***
- **Primary hypothyroidism** leads to increased **TRH** (thyrotropin-releasing hormone) from the hypothalamus. TRH stimulates both **TSH** (thyroid-stimulating hormone) and **prolactin** release from the pituitary, causing hyperprolactinemia [1].
- Elevated prolactin then inhibits **GnRH** (gonadotropin-releasing hormone) secretion, leading to reduced LH and FSH, which results in **anovulation** and **amenorrhea**.
*Stress*
- While acute stress can transiently increase **prolactin levels**, severe and chronic stress typically leads to **hypogonadism** via effects on GnRH, but not usually hyperprolactinemia sufficient to cause prolonged amenorrhea.
- Stress-induced amenorrhea is more often related to **functional hypothalamic amenorrhea**, characterized by low or normal prolactin, and is primarily a disorder of GnRH pulse generation.
*Eating disorders*
- Conditions like **anorexia nervosa** or **bulimia nervosa** can cause amenorrhea due to **low body weight** and nutritional deficiencies, leading to **hypothalamic dysfunction** and low estrogen levels [3].
- These disorders typically result in **hypogonadotropic hypogonadism** (low LH, FSH, and estrogen) rather than **hyperprolactinemia**.
*Adrenal disorders*
- Adrenal disorders like **Cushing's syndrome** or **adrenal insufficiency** can cause menstrual irregularities and amenorrhea, but they are not typically associated with **hyperprolactinemia** [2].
- **Congenital adrenal hyperplasia (CAH)** can cause androgen excess and menstrual irregularities, but prolactin levels are usually normal.
Ovulatory Disorders Indian Medical PG Question 6: A 27-year-old female presented to OPD of infertility clinic. She was prescribed bromocriptine. What could be the possible reason?
- A. Hypogonadotropic hypogonadism
- B. Hyperprolactinemia (Correct Answer)
- C. Pelvic inflammatory disease
- D. Polycystic ovary syndrome
Ovulatory Disorders Explanation: ***Hyperprolactinemia***
- **Bromocriptine** is a **dopamine agonist** that effectively reduces elevated prolactin levels, which can cause anovulation and infertility.
- High prolactin can inhibit GnRH release leading to impaired follicular development and **infertility**.
*Hypogonadotropic hypogonadism*
- This condition involves low levels of **gonadotropins (LH and FSH)**, leading to reduced ovarian function.
- Treatment typically involves **gonadotropin therapy** (e.g., FSH and LH agonists), not bromocriptine.
*Pelvic inflammatory disease*
- PID is an infection of the female reproductive organs, often leading to **fallopian tube blockage** and infertility.
- Treatment involves **antibiotics** to clear the infection and often surgical correction, not bromocriptine.
*Polycystic ovary syndrome*
- PCOS is a hormonal disorder characterized by **anovulation**, hyperandrogenism, and polycystic ovaries.
- Management often includes **lifestyle modifications**, metformin, clomiphene citrate, or letrozole, not primarily bromocriptine, unless there is co-existing hyperprolactinemia.
Ovulatory Disorders Indian Medical PG Question 7: A major causal factor in some cases of hypogonadism is:
- A. Reduced secretion of gonadotropin-releasing hormone (GnRH) (Correct Answer)
- B. Excess secretion of testicular activin by Sertoli cells
- C. Hypersecretion of pituitary LH and FSH as the result of increased GnRH
- D. Failure of the hypothalamus to respond to testosterone
Ovulatory Disorders Explanation: ***Reduced secretion of gonadotropin-releasing hormone (GnRH)***
- **Hypogonadotropic hypogonadism** is characterized by low levels of LH and FSH due to inadequate GnRH secretion from the hypothalamus, leading to decreased testosterone production.
- This can be caused by various factors, including genetic conditions, hypothalamic tumors, or functional suppression from stress or severe illness.
*Excess secretion of testicular activin by Sertoli cells*
- **Activin** promotes FSH synthesis and secretion from the pituitary but is not a primary cause of hypogonadism.
- While disruptions in activin/inhibin balance can affect spermatogenesis, it doesn't directly cause a systemic hypogonadal state through its direct effect on GnRH or gonadal function.
*Hypersecretion of pituitary LH and FSH as the result of increased GnRH*
- **Hypersecretion of LH and FSH** in response to increased GnRH would lead to **hypergonadism**, or at least eugonadism, not hypogonadism.
- This scenario would stimulate excessive testosterone production, the opposite of hypogonadism.
*Failure of the hypothalamus to respond to testosterone*
- The hypothalamus, as well as the pituitary, are sensitive to **negative feedback from testosterone** to regulate GnRH and gonadotropin release.
- A failure to respond to testosterone would typically lead to **increased GnRH and gonadotropin secretion** (as the feedback loop is broken), resulting in higher testosterone levels, which contradicts hypogonadism.
Ovulatory Disorders Indian Medical PG Question 8: Which of the following statements about clomiphene citrate is true?
- A. Enclomiphene has antiestrogenic effects. (Correct Answer)
- B. The risk of multiple pregnancies is less than 1%.
- C. It is contraindicated in male hypogonadism.
- D. The chance of pregnancy is modestly increased compared to placebo.
Ovulatory Disorders Explanation: ***Enclomiphene has antiestrogenic effects.***
- Clomiphene citrate is a racemic mixture of two stereoisomers, **enclomiphene** (trans-isomer) and **zuclomiphene** (cis-isomer).
- **Enclomiphene** is the more potent antiestrogenic isomer, which blocks estrogen receptors in the hypothalamus and pituitary, leading to increased **gonadotropin-releasing hormone (GnRH)** secretion and subsequent **follicle-stimulating hormone (FSH)** and **luteinizing hormone (LH)** release.
- This mechanism is responsible for its effectiveness in inducing ovulation.
*The chance of pregnancy is modestly increased compared to placebo.*
- This is **incorrect** - Clomiphene citrate **significantly** increases the chances of ovulation and pregnancy in anovulatory women, representing much more than a modest increase.
- Studies show substantial improvement in ovulation rates (70-80%) and live birth rates (30-40%) with clomiphene compared to placebo in women with anovulatory infertility.
*The risk of multiple pregnancies is less than 1%.*
- This is **incorrect** - The risk of multiple pregnancies with clomiphene citrate is actually **5-10%**, primarily twins (5-8%), with less than 1% for triplets or higher-order multiples.
- This represents a significant increase compared to spontaneous conception rates (~1-2% twins naturally).
*It is contraindicated in male hypogonadism.*
- This is **incorrect** - Clomiphene citrate is actually used **off-label** in men with **hypogonadism** to stimulate endogenous testosterone production.
- In men, it works by blocking estrogen receptors at the hypothalamic-pituitary level, leading to increased GnRH, LH, and FSH secretion, which stimulates **Leydig cells** to produce testosterone and **Sertoli cells** to support spermatogenesis.
Ovulatory Disorders Indian Medical PG Question 9: Spinnbarkeit is maximum shown at which phase?
- A. Menstrual phase
- B. Ovulatory (Correct Answer)
- C. Post ovulatory
- D. Follicular phase
Ovulatory Disorders Explanation: ***Ovulatory***
- **Spinnbarkeit** refers to the stringy, stretchy quality of cervical mucus, which is maximal during the ovulatory phase due to high **estrogen levels**.
- This highly elastic mucus facilitates **sperm transport** to the uterus and fallopian tubes for fertilization.
*Menstrual phase*
- During the menstrual phase, **cervical mucus** is typically minimal and sticky, making it unfavorable for sperm survival.
- This phase is characterized by low estrogen and progesterone levels, leading to the **shedding of the uterine lining**.
*Post ovulatory*
- After ovulation, under the influence of **progesterone**, cervical mucus becomes thick, sticky, and opaque, decreasing **spinnbarkeit**.
- This change in mucus consistency forms a **barrier to sperm penetration** into the uterus.
*Follicular phase*
- In the early follicular phase, **estrogen levels** are low, resulting in thick, scanty, and opaque cervical mucus with low **spinnbarkeit**.
- As the follicular phase progresses and estrogen levels rise, the mucus gradually becomes more **watery and elastic**, but it doesn't reach its peak stretchiness until ovulation.
Ovulatory Disorders Indian Medical PG Question 10: Therapeutic options for a 30 year old woman suffering from severe pain due to endometriosis are the following except:
- A. Mirena
- B. Letrozole
- C. Sildenafil (Correct Answer)
- D. Oral contraceptives
Ovulatory Disorders Explanation: ***Sildenafil***
- **Sildenafil** is a **vasodilator** primarily used for **erectile dysfunction** and **pulmonary hypertension**.
- It has no established role in the **endocrine** or **anti-inflammatory** management required for endometriosis pain.
*Mirena*
- **Mirena** (levonorgestrel-releasing intrauterine system) is an effective treatment for endometriosis pain because it releases **progestin**, which **suppresses endometrial growth** and inflammation.
- It helps reduce both **dysmenorrhea** and **chronic pelvic pain** associated with endometriosis.
*Letrozole*
- **Letrozole** is an **aromatase inhibitor** that reduces **estrogen synthesis**, which is crucial because endometriosis is an **estrogen-dependent** condition.
- By lowering estrogen levels, it can significantly **reduce pain** and the progression of endometrial implants.
*Oral contraceptives*
- **Combined oral contraceptives (COCs)** are a common and effective first-line treatment for endometriosis pain, as they create a **pseudo-pregnancy state** and **suppress ovulation**.
- This suppression leads to a reduction in **estrogen-driven endometrial growth** and subsequent pain.
More Ovulatory Disorders Indian Medical PG questions available in the OnCourse app. Practice MCQs, flashcards, and get detailed explanations.
